Munro Partners
WST icon

Munro Partners’s West Pharmaceutical WST Stock Holding History

Munro Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.6M Buy
+15,107
New +$5.33M 0.13% 58

Other funds holding WST

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $54.9B AUM 27.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Munro Partners's WST Position: Q3 2026 in Review

Munro Partners opened a new position in West Pharmaceutical (WST) in Q3 2026: 15,107 shares worth $5.6M. The stake represents 0.13% of the portfolio and ranks #58 among its holdings.

716 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Munro Partners held 15,107 shares of West Pharmaceutical worth $5.6M as of Q3 2026.
  • West Pharmaceutical was a new Munro Partners position in Q3 2026.
  • West Pharmaceutical made up 0.13% of Munro Partners's portfolio in Q3 2026, its #58 holding.
  • 716 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Munro Partners's 13F filing for Q3 2026, filed 10 Nov 2026.